Please login to the form below

Not currently logged in
Email:
Password:

GSK to operate lab service for 2012 Games

GlaxoSmithKline (GSK) will provide facilities and equipment to implement anti-doping plans at the 2012 Olympic and Paralympic Games

GlaxoSmithKline (GSK) will provide facilities and equipment to implement anti-doping plans at the 2012 Olympic and Paralympic Games. The London Organising Committee of the Games made the announcement today.

GSK will be the official laboratory services provider in a tier three deal, with GSK providing the facilities to enable King's College London to operate a World Anti-Doping Agency (WADA)  accredited satellite laboratory at the Games.

Thousands of samples will be analysed, with the laboratory in operation 24 hours a day.

Andrew Witty, CEO of GSK said: "The Olympic Games and Paralympic Games provide GSK with a huge opportunity to be part of the delivery of an outstanding world event.

"I'm delighted we've put this alliance with King's College London together to ensure that excellent science can play a key role in ensuring the Games are conducted to the highest ethical standards and that athletes can lead healthier lives. The Olympic and Paralympic ideals of people striving to achieve their best are core to those of GSK, as we share those values of excellence. There is great alignment in these missions and I look forward to our people making a significant contribution to the Olympic Games and Paralympic Games."

30th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics